🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Blood Flow Restriction Training For The Treatment Of Lateral Epicondylopathy

RecruitingNAAges 18 Years - 65 YearsAllTechnical University of Munich
NCT07172568 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * diagnosis of lateral epicondylitis * duration of symptoms \> 6 weeks * failed physical therapy * absence of x-ray abnormalities * written and informed consent Exclusion Criteria: * prior joint infiltrations * duration of symptoms \> 12 months * concomitant rheumatoid diseases * concomitant elbow pathologies, including medial epicondylitis * concomitant radicular symptoms of the cervical spine, shoulder or hand * traumatic etiology of symptoms
💊

What it tests

  • Blood Flow Restriction
  • sham-Blood Flow Restriction
📍

Where

1 site
Department of Sports Orthopaedics, Technical University of Munich
Munich, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy